Recent CMND News
- Clearmind Medicine Granted Patent Approval in Hong Kong for its Binge Behaviors Treatment • GlobeNewswire Inc. • 06/28/2024 11:55:00 AM
- Clearmind Medicine Secured Exclusive Global Rights to Innovative Psychedelic Compounds for PTSD Treatment • GlobeNewswire Inc. • 06/20/2024 11:57:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 06/13/2024 08:01:54 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 06/13/2024 08:01:28 PM
- Clearmind Medicine Revolutionizes the $13 Billion NonAlcoholic Beverages Market with its Psychedelic-Based Drink • GlobeNewswire Inc. • 06/11/2024 11:44:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 05/10/2024 08:01:10 PM
- Clearmind Medicine Advances its Proprietary Psychedelic- Based Synthetic Alcohol Beverage Product • GlobeNewswire Inc. • 05/10/2024 12:24:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 05/07/2024 08:01:25 PM
- Clearmind Medicine Secures Exclusive Global Rights to Breakthrough Psychedelic Compounds for PTSD Treatment • GlobeNewswire Inc. • 05/07/2024 11:46:00 AM
- Clearmind Applies to Cease Being a Reporting Issuer in Canada • GlobeNewswire Inc. • 04/30/2024 08:15:00 PM
- Clearmind Medicine Announces Exclusive Licensing Agreement for Generation 3.0 Psychedelic Compounds for the Treatment of Mental Disorders • GlobeNewswire Inc. • 04/17/2024 11:49:00 AM
- Clearmind Medicine Files U.S. Patent Application for Psychedelic-Based Treatment for Eating Disorders • GlobeNewswire Inc. • 04/10/2024 11:17:00 AM
- Clearmind Medicine CEO Issues Letter to Shareholders • GlobeNewswire Inc. • 04/09/2024 12:07:00 PM
- Breakthrough in Wellness: Clearmind Medicine's Psychedelic Treatment Granted Divisional Patent Approval in China • GlobeNewswire Inc. • 03/19/2024 11:55:00 AM
- Clearmind Medicine Obtains Clearance for its Psychedelic- Based Alcoholism Clinical Trial • GlobeNewswire Inc. • 03/13/2024 12:14:00 PM
- Clearmind Medicine Received Approval for a Voluntary Delisting of its Common Shares From the Canadian Securities Exchange • GlobeNewswire Inc. • 03/13/2024 11:30:00 AM
- Clearmind Medicine Submits Three Additional International Patent Applications for Innovative MDMA, Ibogaine and Ketamine Compounds • GlobeNewswire Inc. • 02/27/2024 12:58:00 PM
- SciSparc-Clearmind Partnership Yields Three New International Patent Applications for MDMA, Ibogaine and Ketamine Compounds • GlobeNewswire Inc. • 02/27/2024 12:58:00 PM
- Clearmind Medicine Receives Approval to Commence its Phase I/IIa Clinical Trial of CMND-100 for Alcohol Use Disorder • GlobeNewswire Inc. • 02/23/2024 12:06:00 PM
- Clearmind Medicine Submits Three International Patent Applications for Next Generation Classic Psychedelic-Based Compounds • GlobeNewswire Inc. • 02/20/2024 12:14:00 PM
- SciSparc and Clearmind Continue to Strengthen International Patent Portfolio with Next Generation Classic Psychedelic-Based Compounds • GlobeNewswire Inc. • 02/20/2024 12:14:00 PM
- Clearmind Medicine Receives Patent Approval for its Psychedelic Based Treatment of Binge Behaviors in China • GlobeNewswire Inc. • 02/05/2024 12:51:00 PM
- Clearmind Medicine Announces Exclusive, Long-Term Licensing Agreement with Leading Israeli Research Center • GlobeNewswire Inc. • 02/01/2024 01:15:00 PM
- Clearmind Medicine Inc. Closes US$2.4 Million Registered Direct and Private Placement • GlobeNewswire Inc. • 01/16/2024 04:19:34 PM
- Clearmind Medicine Inc. Announces Pricing of $2.4 Million Registered Direct and Private Placement • GlobeNewswire Inc. • 01/11/2024 02:28:00 PM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM